UK-listed financial and energy firms posted robust operational updates today, led by **Wise Group** reporting a 21% jump in Q2 net revenue to $739.1 million alongside strong cross-border volume, while global asset manager **Man Group** saw its assets under management reach $270.9 billion on $10.1 billion of net quarterly inflows. In wealth management and healthcare, **Aviva** set ambitious long-term goals targeting over £500 million in divisional operating profit by 2032, and **IP Group** backed portfolio company Microbiotica in a £36 million Series C raise to fund Phase 2 clinical trials. The energy sector saw significant structural shifts as **Nostrum Oil & Gas** completed the $304.6 million sale of its Kazakhstan operations to fully redeem its 2026 debt, **Aura Energy** delivered a US$500.3 million NPV bankable feasibility study for its Tiris Uranium Project, and **Ithaca Energy** announced CEO Luciano Vasques will retire by March 2027.
International money transfer specialist Wise Group WISE delivered a 21% increase in quarterly net revenue to $739.1 million for the second quarter of FY27. Cross-border transaction volumes reached $71.7 billion, driven by a 20% year-on-year expansion in active customer accounts to 12.5 million. The group's cross-border take rate adjusted down to 0.49% as part of a strategy to reinvest operational efficiencies into lower pricing for users. Total customer holdings increased 28% to $43.5 billion, reflecting higher adoption of broader Wise account features.
Alternative asset manager Man Group EMG expanded its total assets under management to $270.9 billion during the third quarter of 2026. Net inflows for the three-month period reached $10.1 billion, underpinned by strong demand for long-only equity strategies ($5.8 billion) and liquid alternative products ($1.9 billion). Positive investment performance added a further $5.9 billion to overall assets. The group maintained positive momentum across both alternative and long-only investment categories.
Insurance and financial services group Aviva AV. hosted an investor update outlining growth projections for its Wealth division. Chief Executive Amanda Blanc confirmed the business is on schedule to generate £280 million in Wealth operating profit by 2027, while setting a longer-term goal to exceed £500 million by 2032. Industry forecasts presented by the group project the UK wealth market asset pool to reach £7.5 trillion by 2035, driven by structural demand and new technology adoption. Aviva remains the largest provider in the UK wealth sector by total assets under management.
Energy producer Nostrum Oil & Gas NOG confirmed the completion of its Kazakhstan business disposal to Altaris Holding for $304.6 million. Following transaction close, the group funded the full redemption of its 2026 Senior Secured Notes, extinguishing all outstanding bond debt. The transaction represents a material corporate restructuring that significantly simplifies the company's operating structure and balance sheet profile. Final purchase price adjustments will be calculated following completion protocol.
North Sea oil producer Ithaca Energy ITH announced that Chief Executive Officer Luciano Vasques will retire from the business by March 2027. Vasques spearheaded significant structural expansion at the company, including the integration of Eni UK assets and securing entry into the FTSE 100 index. The board has initiated a formal recruitment process to select a replacement ahead of his departure. The deliberate timeline aims to ensure an orderly leadership transition over the coming months.
Uranium developer Aura Energy AURA released positive Bankable Feasibility Study results for its flagship Tiris Uranium Project in Mauritania. The assessment outlines a post-tax net present value of US$500.3 million based on an 8% discount rate and an internal rate of return of 28%. Separately, the group's quarterly operations update confirmed executive appointments made to transition the asset from study phase into construction ahead of a Final Investment Decision. Onsite pilot plant construction and project financing arrangements continue to advance.
Intellectual property investor IP Group IPO announced that clinical-stage biopharma portfolio firm Microbiotica successfully raised £36 million in Series C financing. The funds will support Phase 2 trials for an oral microbiome treatment for ulcerative colitis following positive Phase 1b clinical results. IP Group contributed £4 million to the financing round, maintaining a 16.4% beneficial stake valued at £24.1 million. The fundraise attracted backing from the British Business Bank, Tencent, and specialized healthcare investors.
Specialty chemical manufacturer Iofina IOF reported third-quarter crystalline iodine production of 205.2 metric tonnes, affected by maintenance work across its Oklahoma partner sites. Separately, the company confirmed that its largest plant to date, IO#12 in the Permian Basin, has been fully commissioned and transferred to operations. Constructed in partnership with Western Midstream, IO#12 is expected to contribute between 170 and 220 metric tonnes annually. Groundwork for two subsequent expansion plants, IO#13 and IO#14, is set to commence shortly.